118 related articles for article (PubMed ID: 16114863)
21. Antivirals for influenza in healthy adults: systematic review.
Jefferson T; Demicheli V; Rivetti D; Jones M; Di Pietrantonj C; Rivetti A
Lancet; 2006 Jan; 367(9507):303-13. PubMed ID: 16443037
[TBL] [Abstract][Full Text] [Related]
22. High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents--United States, 2005-06 influenza season.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Jan; 55(2):44-6. PubMed ID: 16424859
[TBL] [Abstract][Full Text] [Related]
23. [The use of antiviral agents during an (impending) influenza pandemic].
Opstelten W; van Steenbergen JE; van Essen GA; Van der Sande MA
Ned Tijdschr Geneeskd; 2007 May; 151(18):1008-12. PubMed ID: 17508684
[TBL] [Abstract][Full Text] [Related]
24. Pandemics, avian influenza A (H5N1), and a strategy for pharmacists.
Ford SM; Grabenstein JD
Pharmacotherapy; 2006 Mar; 26(3):312-22. PubMed ID: 16503711
[TBL] [Abstract][Full Text] [Related]
25. Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors.
Hurt AC; Ho HT; Barr I
Expert Rev Anti Infect Ther; 2006 Oct; 4(5):795-805. PubMed ID: 17140356
[TBL] [Abstract][Full Text] [Related]
26. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.
Ilyushina NA; Hoffmann E; Salomon R; Webster RG; Govorkova EA
Antivir Ther; 2007; 12(3):363-70. PubMed ID: 17591026
[TBL] [Abstract][Full Text] [Related]
27. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
[TBL] [Abstract][Full Text] [Related]
28. [Epidemiology, clinical picture, prevention and treatment of Avian influenza].
Angelava NA; Angelava AV
Georgian Med News; 2006 Feb; (131):69-76. PubMed ID: 16575138
[TBL] [Abstract][Full Text] [Related]
29. Oseltamivir: new indication. Prevention of influenza in at-risk children: vaccination is best.
Prescrire Int; 2007 Feb; 16(87):9-11. PubMed ID: 17323516
[TBL] [Abstract][Full Text] [Related]
30. [Various sides of influenza. Part II--epidemiology, influenza surveillance and prophylaxis].
Machała MK; Brydak LB
Pol Merkur Lekarski; 2006 Sep; 21(123):277-85. PubMed ID: 17163191
[TBL] [Abstract][Full Text] [Related]
31. Emergence of drug-resistant influenza virus: population dynamical considerations.
Regoes RR; Bonhoeffer S
Science; 2006 Apr; 312(5772):389-91. PubMed ID: 16627735
[TBL] [Abstract][Full Text] [Related]
32. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza.
McCullers JA
J Infect Dis; 2004 Aug; 190(3):519-26. PubMed ID: 15243927
[TBL] [Abstract][Full Text] [Related]
33. A designer drug against influenza: the NA inhibitor oseltamivir (Tamiflu).
Oxford JS; Mann A; Lambkin R
Expert Rev Anti Infect Ther; 2003 Aug; 1(2):337-42. PubMed ID: 15482128
[TBL] [Abstract][Full Text] [Related]
34. Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice.
Ferraris O; Kessler N; Lina B
Antiviral Res; 2005 Oct; 68(1):43-8. PubMed ID: 16125799
[TBL] [Abstract][Full Text] [Related]
35. Anti-influenza drugs: the development of sialidase inhibitors.
von Itzstein M; Thomson R
Handb Exp Pharmacol; 2009; (189):111-54. PubMed ID: 19048199
[TBL] [Abstract][Full Text] [Related]
36. Adamantane resistance in influenza A(H1) viruses increased in 2007 in South East Asia but decreased in Australia and some other countries.
Barr IG; Deng YM; Iannello P; Hurt AC; Komadina N
Antiviral Res; 2008 Nov; 80(2):200-5. PubMed ID: 18611414
[TBL] [Abstract][Full Text] [Related]
37. Modifying clinical practices to manage influenza in children effectively.
Glezen WP
Pediatr Infect Dis J; 2008 Aug; 27(8):738-43. PubMed ID: 18664986
[TBL] [Abstract][Full Text] [Related]
38. Mutations of neuraminidase implicated in neuraminidase inhibitors resistance.
Ferraris O; Lina B
J Clin Virol; 2008 Jan; 41(1):13-9. PubMed ID: 18055254
[TBL] [Abstract][Full Text] [Related]
39. Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.
Magano J
Chem Rev; 2009 Sep; 109(9):4398-438. PubMed ID: 19537777
[No Abstract] [Full Text] [Related]
40. [Human influenza].
Stock I
Med Monatsschr Pharm; 2006 Oct; 29(10):360-8; quiz 369-70. PubMed ID: 17058895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
